Programming the lifestyles of engineered bacteria for cancer therapy. Issue 5 (14th February 2023)

• Record Type: Journal Article
• Authors: Fu, Shengwei; Zhang, Rongrong; Gao, Yanmei; Xiong, Jiarui; Li, Ye; Pu, Lu; Xia, Aiguo; Jin, Fan
• Is Part Of: National science review. Volume 10:Issue 5(2023)
• Publication Date: 2023-02-14
• Subjects: genetic engineering -- drug delivery -- cancer therapy -- optogenetics -- synthetic biology; Science -- Periodicals; 505
• DOI: 10.1093/nsr/nwad031
• Languages: English
• ISSNs: 2095-5138

Abstract

ABSTRACT: Bacteria can be genetically engineered to act as therapeutic delivery vehicles in the treatment of tumors, killing cancer cells or activating the immune system. This is known as bacteria-mediated cancer therapy (BMCT). Tumor invasion, colonization and tumor regression are major biological events, which are directly associated with antitumor effects and are uncontrollable due to the influence of tumor microenvironments during the BMCT process. Here, we developed a genetic circuit for dynamically programming bacterial lifestyles (planktonic, biofilm or lysis), to precisely manipulate the process of bacterial adhesion, colonization and drug release in the BMCT process, via hierarchical modulation of the lighting power density of near-infrared (NIR) light. The deep tissue penetration of NIR offers us a modality for spatio-temporal and non-invasive control of bacterial genetic circuits in vivo . By combining computational modeling with a high-throughput characterization device, we optimized the genetic circuits in engineered bacteria to program the process of bacterial lifestyle transitions by altering the illumination scheme of NIR. Our results showed that programming intratumoral bacterial lifestyle transitions allows precise control of multiple key steps throughout the BMCT process and therapeutic efficacy can be greatly improved by controlling the localization and dosage of therapeutic agents via optimizing the illumination scheme. Abstract : Programming intratumoral bacterial life style transitions allow precise control of multiple key steps throughout the bacteria-mediated cancer therapy process and therapeutic efficacy can be greatly improved by controlling the localization and dosage of therapeutic agents via optimizing the illumination scheme.